Cadila Healthcare reports 22% fall in Q4 consolidated net profit

29 May 2019 Evaluate

Cadila Healthcare has reported results for fourth quarter and year ended March 31, 2019.

The company has reported a rise of 7.77% in its net profit at Rs 262.10 crore for the quarter under review as compared to Rs 243.20 crore for the same quarter in the previous year. Total income of the company increased by 14.19% at Rs 1,713.90 crore for Q4FY19 as compared Rs 1,500.90 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported a fall of 22.12% in its net profit at Rs 460.10 crore for the quarter under review as compared to Rs 590.80 crore for the same quarter in the previous year. However, total income of the company increased by 14.91% at Rs 3,771.20 crore for Q4FY19 as compared Rs 3,281.80 crore for the corresponding quarter previous year.

For the year ended March 31, 2019, the company has reported a rise of 46.87% in its net profit at Rs 1,602.10 crore as compared to Rs 1,090.80 crore for the previous year. Total income of the company increased by 17.81% at Rs 7,104.30 crore for year under review as compared to Rs 6,030.50 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has reported a rise of 4.11% in its net profit at Rs 1,848.80 crore as compared to Rs 1,775.80 crore for the previous year. Total income of the company increased by 10.77% at Rs 13,366.70 crore for year under review as compared to Rs 12,067.60 crore for year ended March 31, 2018.

Zydus Lifesciences Share Price

896.60 3.15 (0.35%)
28-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1610.15
Dr. Reddys Lab 1224.30
Cipla 1328.25
Zydus Lifesciences 896.60
Lupin 2121.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×